LeonaBio, Inc.

LeonaBio, Inc.

LONA - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$8.77M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
LeonaBio, Inc.LeonaBio, Inc.-0.1--974%--
$15.00

Target Price by Analysts

631.7% upsideLeonaBio Target Price DetailsTarget Price
$16.01

Current Fair Value

681.2% upside

Undervalued by 681.2% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$8.77 Million
Enterprise Value$-7,110,688.00
Earnings per Share$-24.7
Beta1.92
Outstanding Shares4,275,762

Return

Return on Equity-974.02%ROE
Return on Assets-409.08%
Return on Invested Capital-445.91%

Valuation & Multiples

P/E Ratio-0.11P/E Ratio
PEG-0.05PEG
Price to Sales-Price to Sales
Price to Book Ratio0.68Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT0.02
Enterprise Value to Net Income0
Total Debt to Enterprise-0.21
Debt to Equity0.03Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 19, 2026
EPS Estimate
-$0.69
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Next Earnings Call

Expected Date
March 25, 2027
EPS Estimate
-$0.65
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Athira Pharma Inc

19 employees
CEO: Mark J. Litton

LeonaBio, Inc. operates as a biopharmaceutical firm engaged in clinical-stage development. Its core mission revolves around crafting small molecule therapies aimed at revitalizing neurological function and arresting the advancement of ne...

LeonaBio Insider Information FAQ

Stockcircle shows 1 open-market insider purchase for LeonaBio in the last six months from SEC Form 4 reports by executives, directors, and other insiders.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.